This review summarizes the available data on risk factors for sudden cardiac death in hypertrophic cardiomyopathy, emphasizing the need for prospective trials to develop diagnostic and therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Current risk stratification for sudden death in HCM lacks precision for most patients; leaves open the need for prospective trials to refine approaches.
Maron et al. (1994) studied this question.